Analyst Ratings for Protalix BioTherapeutics (PLX) [Buys]
PLX Rating Summary
PLX Price Target Summary
- Highest: $9.00 (Auriga)
- Lowest: $5.50 (Jefferies)
- Average: $6.88
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$6.88 (+33.8%)
Avg. $ Target:
$6.88 (+33.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/4/2012 | Auriga » Updated 5/10/2012 |
Upgrade | Buy (N/A) |
9.00 (N/A) |
6.73 | 5.14 | -23.63% | Details |
| 3/17/2011 | WBB Securities | Downgrade | Buy (N/A) |
N/A (N/A) |
6.21 | 5.14 | -17.23% | Details |
